Financial analysis: Pfizer vs. Johnson&Johnson
Case Analysis
Introduction to Finance
Introduction – The companies’ profile
We chose Johnson and Johnson as a company for our case analysis, and researches have shown that one of its main competitors is Pfizer, Inc.
Johnson and Johnson is ranked as the world’s most respected company, and as number 50 in Forbes Top 100 World’s Most Powerful Brands: it is a veritable empire. But as we say, “Rome wasn’t built in a day”.
Johnson and Johnson was founded in 1886 by Brothers Robert and James Johnson, and is headquartered since then in New Brunswick. It started as a simple Surgical Dressing company, but is now renowned for its diversity and its clean Judiciary aspects. Its products range from Pharmaceuticals to consumers goods and even Network Publishing.
It is considered to be a Family Company as it globes more than 230 subsidiaries. This “Family” comprises:
The world’s sixth-largest consumer health company
The world’s largest and most diverse medical devices and diagnostics company
The world’s fifth-largest biologics company
And the world’s eighth-largest pharmaceuticals company
Today, Johnson and Johnson is listed on the New York Stock Exchange. It is generating 65 Billion Dollars of revenue with a 10 Billion Dollars net income, and is becoming one of the most important Holding Companies. Its opening share Price is 77.92 dollars with a volume of 4.364.877 and its market capital is 213,59 Billion dollars.
Pfizer, Inc. is the world’s largest pharmaceutical company by revenues. Cousins and chemical experts Charles Pfizer and Charles Erhart founded it in 1849 as a Fine Chemicals Production Company. The enterprise itself is headquartered in NYC, yet its Research Labs are mainly located in Connecticut. They develop and produce medicines and vaccines for a wide array of medical situations ranging from regular pain to immunology and inflammation.
In 2007, Pfizer invested $8.1 billion in research and development, the largest
Introduction to Finance
Introduction – The companies’ profile
We chose Johnson and Johnson as a company for our case analysis, and researches have shown that one of its main competitors is Pfizer, Inc.
Johnson and Johnson is ranked as the world’s most respected company, and as number 50 in Forbes Top 100 World’s Most Powerful Brands: it is a veritable empire. But as we say, “Rome wasn’t built in a day”.
Johnson and Johnson was founded in 1886 by Brothers Robert and James Johnson, and is headquartered since then in New Brunswick. It started as a simple Surgical Dressing company, but is now renowned for its diversity and its clean Judiciary aspects. Its products range from Pharmaceuticals to consumers goods and even Network Publishing.
It is considered to be a Family Company as it globes more than 230 subsidiaries. This “Family” comprises:
The world’s sixth-largest consumer health company
The world’s largest and most diverse medical devices and diagnostics company
The world’s fifth-largest biologics company
And the world’s eighth-largest pharmaceuticals company
Today, Johnson and Johnson is listed on the New York Stock Exchange. It is generating 65 Billion Dollars of revenue with a 10 Billion Dollars net income, and is becoming one of the most important Holding Companies. Its opening share Price is 77.92 dollars with a volume of 4.364.877 and its market capital is 213,59 Billion dollars.
Pfizer, Inc. is the world’s largest pharmaceutical company by revenues. Cousins and chemical experts Charles Pfizer and Charles Erhart founded it in 1849 as a Fine Chemicals Production Company. The enterprise itself is headquartered in NYC, yet its Research Labs are mainly located in Connecticut. They develop and produce medicines and vaccines for a wide array of medical situations ranging from regular pain to immunology and inflammation.
In 2007, Pfizer invested $8.1 billion in research and development, the largest